OSCR

Systematic proteomics reveals plasma NEFL as a robust predictor and pathological associate in <i>C9ORF72</i>-related neurodegeneration.

Overview

Authors: Zhen Hu1,2, Jing-jin Wan3, Qin-qin Yan4, Yu Fan2, Jun Liu2
  1. Department of Neurology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  2. Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  3. Department of Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  4. Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Institutions: Shanghai Jiao Tong University (China); Ruijin Hospital (China); Renji Hospital (China)
Journal: Frontiers in aging neuroscience, volume 18, article 1792887
Dates: received 21 January 2026; accepted 31 March 2026; published online 21 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fnagi.2026.1792887 · PMID 42095061 · PMCID PMC13139100 · OpenAlex W7155052314
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), human (organism), other condition (population)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning
Keywords: C9ORF72, motor neuron disease (MND), NEFL, neurodegeneration, repeat expansion
Topic: Amyotrophic Lateral Sclerosis Research (Clinical Neurology, Medicine), according to OpenAlex
Funding: National Natural Science Foundation of China (#81873778, 82230040, 82401649, #82071415); China Postdoctoral Science Foundation (2024M752018)
Citations: not cited yet (Europe PMC); 25 references in the paper

Abstract

Background: The C9ORF72 repeat expansion is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). While neurofilament light chain (NEFL) is an established biomarker of neuroaxonal damage, its specific dose-response relationship with the C9ORF72 expansion and its potential role beyond a passive bystander require systematic investigation. We performed a proteome-wide screen to identify plasma proteins linked to the C9ORF72 expansion and evaluated their predictive value for motor neuron disease (MND).

Methods: We utilized whole-genome sequencing and plasma proteomics from the UK Biobank, analyzing 106 individuals with C9ORF72 expansions (defined as >30 repeats) and 212 age- and sex-matched controls. We screened ~3,000 proteins for associations with the continuous repeat count. The top candidate was evaluated using restricted cubic splines (RCS) to assess non-linearity and threshold effects. Its ability to independently predict MND risk was tested using regression models and a machine learning approach.

Results: Our unbiased screen identified NEFL as the sole protein significantly associated with the C9ORF72 repeat count (FDR-adjusted P = 8.39 × 10−4). NEFL levels demonstrated a step-wise increase with expansion size, which followed a stable linear trajectory across the repeat spectrum (Pnon − linear = 0.4435). Elevated NEFL independently predicted MND risk (OR = 2.42; HR = 2.90), even after adjusting for the C9ORF72 repeat count. Our predictive model, combining NEFL and repeat count, achieved an AUC of 0.941 with 100% sensitivity. These findings align with emerging evidence that secreted NEFL may actively modulate neuroinflammation.

Conclusions: NEFL emerges as a robust and specific plasma biomarker for C9ORF72-related neurodegeneration. Its strong linear association with repeat burden and independent predictive power, contextualized within its potential role in immune activation, suggest that NEFL is deeply integrated into the C9ORF72 pathological landscape. These findings support NEFL-based screening and monitoring strategies for early intervention in C9ORF72 carriers.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

Data used in this study are available from the UK Biobank (accession number 162635) through the UK Biobank Access Management System (https://www.ukbiobank.ac.uk/). Plasma proteomics data were obtained from the UK Biobank Pharma Proteomics Project (Olink platform). Derived data fields generated in this study will be returned to the UK Biobank in accordance with their data sharing policies.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 5 authors, 5 keywords, 2 funders, 25 references.

Cite

This paper

Hu, Z., Wan, J.-j., Yan, Q.-q., Fan, Y., & Liu, J. (2026). Systematic proteomics reveals plasma NEFL as a robust predictor and pathological associate in <i>C9ORF72</i>-related neurodegeneration. Frontiers in aging neuroscience, 18, 1792887. https://doi.org/10.3389/fnagi.2026.1792887

BibTeX

@article{hu2026systematic,
author = {Hu, Zhen and Wan, Jing-jin and Yan, Qin-qin and Fan, Yu and Liu, Jun},
title = {{Systematic proteomics reveals plasma NEFL as a robust predictor and pathological associate in \<i\>C9ORF72\</i\>-related neurodegeneration}},
journal = {Frontiers in aging neuroscience},
year = {2026},
month = apr,
volume = {18},
pages = {1792887},
publisher = {Frontiers Media SA},
issn = {1663-4365},
doi = {10.3389/fnagi.2026.1792887},
url = {https://doi.org/10.3389/fnagi.2026.1792887},
pmid = {42095061},
pmcid = {PMC13139100}
}

RIS

TY - JOUR
AU - Hu, Zhen
AU - Wan, Jing-jin
AU - Yan, Qin-qin
AU - Fan, Yu
AU - Liu, Jun
TI - Systematic proteomics reveals plasma NEFL as a robust predictor and pathological associate in <i>C9ORF72</i>-related neurodegeneration
T2 - Frontiers in aging neuroscience
J2 - Front Aging Neurosci
PY - 2026
DA - 2026/04/21
VL - 18
SP - 1792887
SN - 1663-4365
PB - Frontiers Media SA
DO - 10.3389/fnagi.2026.1792887
UR - https://doi.org/10.3389/fnagi.2026.1792887
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fnagi.2026.1792887",
"type": "article-journal",
"title": "Systematic proteomics reveals plasma NEFL as a robust predictor and pathological associate in <i>C9ORF72</i>-related neurodegeneration",
"container-title": "Frontiers in aging neuroscience",
"author": [
{
"family": "Hu",
"given": "Zhen"
},
{
"family": "Wan",
"given": "Jing-jin"
},
{
"family": "Yan",
"given": "Qin-qin"
},
{
"family": "Fan",
"given": "Yu"
},
{
"family": "Liu",
"given": "Jun"
}
],
"container-title-short": "Front Aging Neurosci",
"volume": "18",
"page": "1792887",
"DOI": "10.3389/fnagi.2026.1792887",
"PMID": "42095061",
"PMCID": "PMC13139100",
"ISSN": "1663-4365",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fnagi.2026.1792887",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
21
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fnagi.2025.1735522
Exploring rare coding variants in UK biobank: preliminary associations with motor neuron disease.
Journal: Frontiers in aging neuroscience
In common: ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us, other condition, 4 references
[2] doi:10.1038/s41525-024-00426-8 [code]
Polygenic scores stratify neurodevelopmental copy number variant carrier cognitive outcomes in the UK Biobank.
Journal: NPJ genomic medicine
In common: ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us, genetics / omics, other condition, 1 reference
[3] doi:10.1038/s41467-023-43575-7 [code]
Plasma proteomic profiles predict individual future health risk.
Journal: Nature communications
In common: ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us, genetics / omics, 1 reference
[4] doi:10.1038/s41398-025-03440-1
Neurobiological correlates of schizophrenia-specific and highly pleiotropic genetic risk scores for neuropsychiatric disorders.
Journal: Translational psychiatry
In common: ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us, genetics / omics, 1 reference
[5] doi:10.1161/jaha.123.031514
Suboptimal Sleep Duration Is Associated With Poorer Neuroimaging Brain Health Profiles in Middle-Aged Individuals Without Stroke or Dementia.
Journal: Journal of the American Heart Association
In common: ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us, 1 reference
[6] doi:10.1136/svn-2022-001929
Blood pressure-related white matter microstructural disintegrity and associated cognitive function impairment in asymptomatic adults.
Journal: Stroke and vascular neurology
In common: ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us, 1 reference
[7] doi:10.1162/netn_a_00286
Sex differences in multilayer functional network topology over the course of aging in 37543 UK Biobank participants.
Journal: Network neuroscience (Cambridge, Mass.)
In common: ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us, 1 reference
[8] doi:10.1038/s41593-022-01040-6 [code]
Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3'UTR protect against ALS.
Journal: Nature neuroscience
In common: genetics / omics, other condition, 3 references
[9] doi:10.1186/s13073-026-01702-1
Tandem repeat polymorphisms are associated with brain structure: results of two large population-based studies.
Journal: Genome medicine
In common: genetics / omics, 3 references
[10] doi:10.1038/s41586-026-10345-6 [code]
Population-scale repeat expansions elucidate disease risk and brain atrophy.
Journal: Nature
In common: genetics / omics, other condition, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.